NP
Nutra Pharma Corp.
NPHC · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $716.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
51 /100
Fair P/S 3.46x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 61.32%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 50.38%
Net margin 2,618.79%
FCF margin 507.09%
Quality
60 /100
Average ROIC 18.47%
ROA 870.25%
Asset turnover 0.33x
Debt
0 /100
High Current ratio 0.02x
Int. coverage -5,917.43x
Debt/Equity N/A
Stability
16 /100
Unstable Beta -2.77x
Rev. volatility 202.42%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NPHC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Michael D. Flax
Employees
6
Headquarters
Boca Raton